Main results HbA1c, body weight, and FPG SGLT2i compared to placebo Four RCTs were included, with a total of 626 patients (304 in the SGLT2i group and 322 in the placebo group), which compared the changes in both HbA1c and body weight among patients with T2DM and low cardiovascular disease risk, from baseline to follow-up ( 2 = 0%) ( Figure 2A ) and body weight levels with low heterogeneity (MD: -1.32, 95% CI: -1.82, -0.82
Some studies suggest that it may also help with autoimmune conditions, where the immune system attacks healthy tissues
te yandan baz almalarda tam tersi etkiler bildirilmitir (24, 25)
As the field of Alzheimers research shifts towards combination therapies, we believe our approach holds great promise for offering more effective treatment options for patients. About Buntanetap Buntanetap (formerly known as Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43